Company profile: BioBright
1.1 - Company Overview
Company description
- Provider of scientific lab data automation software that automates the flow of data from laboratory instruments to secure cloud databases. Solutions include the Dotmatics Luma R&D Data Management Platform and Luma Lab Connect to ingest, centralize, standardize, and model data from in-house and external sources in any file format, enable real-time synchronization, easy access and analysis for non-technical users, and low-code app building.
Products and services
- Dotmatics Luma R&D Data Management Platform: Data-centric platform simplifying collection and processing of lab instrument data, automating flow to secure cloud databases, enabling access and analysis for non-technical researchers
- Data Modeling: Customizable capability allowing scientists to tailor data to unique requirements, creating clean, reliable data structures that standardize datasets for in-depth analysis across experiments
- Luma Lab Connect: Format-agnostic ingestion component that automatically pulls and centralizes data from any source, including lab instruments and equipment, accommodating any file format for unified access.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioBright
Aitia
HQ: United States
Website
- Description: Provider of Causal AI and digital twin-based drug discovery solutions. Offers Gemini Digital Twins—computational disease models that simulate genetic and molecular interactions to identify novel drug targets and patient subpopulations—and Causal AI Drug Discovery leveraging multi-omic data to accelerate development of new therapies for neurodegenerative diseases and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aitia company profile →
Aces Health
HQ: United States
Website
- Description: Provider of a clinical trial platform that automates patient engagement and data collection during clinical research trials, builds smarter tools to fight medical nonadherence, and keeps patients on track and motivated. Its flagship app platform connects with over 200 wearable sensors and smart devices and thousands of EMR systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aces Health company profile →
eClinical Solutions
HQ: United States
Website
- Description: Provider of a data intelligence hub that transforms clinical data integration, aggregation, and analytics, leveraging clinical trial expertise and platforms including Rave Clinical Cloud and the elluminate Clinical Data Cloud; offerings include Mapper, Data Central, Clinical Analytics, Risk-Based Quality Management, and eIQ Review to accelerate clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eClinical Solutions company profile →
Enpicom
HQ: The Netherlands
Website
- Description: Provider of innovative bioinformatics software and customized solutions supporting biopharma and academic scientists in accelerating immunotherapy and vaccine discovery and development. Offers the cloud-based IGX Platform for immune repertoire sequencing analysis, plus Antibody Discovery, IGX-Track, IGX-Profile, IGX-Inspect, and IGX-Explore for annotation, QC, clustering, and interactive visualizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enpicom company profile →
Faculty Opinions
HQ: United Kingdom
Website
- Description: Provider of a discovery tool for qualitative assessment of published research, leveraging a faculty of over 8,000 leading life science and medicine experts who comment on and validate key publications. Offers H1 Connect for global health opportunities and training, H1 Profile to build credibility and apply, and a WhatsApp community for global peer collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faculty Opinions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioBright
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioBright
2.2 - Growth funds investing in similar companies to BioBright
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioBright
4.2 - Public trading comparable groups for BioBright
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →